Novel Vaccine Candidates against Tuberculosis - Sorbonne Université
Article Dans Une Revue Current Medicinal Chemistry Année : 2020

Novel Vaccine Candidates against Tuberculosis

Résumé

Ranking above AIDS, Tuberculosis (TB) is the ninth leading cause of death affecting and killing many individuals every year. Drugs' efficacy is limited by a series of problems such as Multi-Drug Resistance (MDR) and Extensively-Drug Resistance (XDR). Meanwhile, the only licensed vaccine BCG (Bacillus Calmette-Guérin) existing for over 90 years is not effective enough. Consequently , it is essential to develop novel vaccines for TB prevention and immunotherapy. This paper provides an overall review of the TB prevalence, immune system response against TB and recent progress of TB vaccine research and development. Several vaccines in clinical trials are described as well as LAM-based candidates.
Fichier principal
Vignette du fichier
2020, 27, 5095-5118 CMC(1).pdf (4.72 Mo) Télécharger le fichier
Origine Accord explicite pour ce dépôt
Loading...

Dates et versions

hal-02901273 , version 1 (17-07-2020)

Identifiants

Citer

Zhihao Li, Changping Zheng, Marco Terreni, Lisa Tanzi, Matthieu Sollogoub, et al.. Novel Vaccine Candidates against Tuberculosis. Current Medicinal Chemistry, 2020, 27 (31), pp.5095 - 5118. ⟨10.2174/0929867326666181126112124⟩. ⟨hal-02901273⟩
85 Consultations
357 Téléchargements

Altmetric

Partager

More